Semler Scientific (OTCMKTS:SMLR) posted its earnings results on Sunday. The medical equipment provider reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.11, MarketWatch Earnings reports. Semler Scientific had a return on equity of 67.38% and a net margin of 32.08%.
OTCMKTS:SMLR traded down $1.25 during trading hours on Tuesday, hitting $112.00. The company had a trading volume of 15,503 shares, compared to its average volume of 18,074. The company has a 50-day moving average of $109.23 and a 200 day moving average of $91.17. The company has a market cap of $752.30 million, a P/E ratio of 78.87, a P/E/G ratio of 1.48 and a beta of 1.11. Semler Scientific has a 1 year low of $39.22 and a 1 year high of $118.97.
SMLR has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded Semler Scientific from a “hold” rating to a “buy” rating and set a $115.00 price objective for the company in a research report on Saturday, February 27th. B. Riley reiterated a “buy” rating and set a $151.00 price target (up from $147.00) on shares of Semler Scientific in a research report on Tuesday.
About Semler Scientific
Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Article: What are Bollinger Bands?
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.